Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Contacts Investors: Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications Phone: (248) 202-9267 Email: ir@evolus.com Media:...
Month: March 2024
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
- Conference call to be held on Thursday, April 4, 2024, at 10:00 a.m. U.S. EDT - REHOVOT, Israel, March...
Leading Biometric Identify Verification & Authentication Firm authID Inc. Appoints Kunal Mehta to its Board of Directors
Company adds expert in global business development, and go-to-market growth strategyDENVER, March 26, 2024 (GLOBE NEWSWIRE) -- authID.ai , a leading provider...
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation and potentially generate human efficacy data in H2 2024U.S. FDA...
Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced...
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
Pet Hip and Joint Health Chews and Pet Calming Care Chews improve the physical and emotional well-being of dogs SAN...
NextPlat Expands North American Technology E-Commerce Business with Acquisition of Outfitter Satellite Inc.
Accretive Acquisition to More Than Double North American Technology E-Commerce Product Sales and Recurring Revenue through Consumer, Commercial and Government Customer...
GDS Announces Landmark US$587 Million Equity Raise For its International Business
SHANGHAI, China, March 26, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (the “Company” or “GDSH”) (NASDAQ: GDS; HKEX: 9698), a...
New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer...
MDM Permian Inc. Announces the Appointment of Michael Cohen to its Advisory Board
DALLAS, TX / ACCESSWIRE / March 26, 2024 / MDM Permian Inc. (OTC PINK:MDMP), an-and-coming player in the development and...
Virpax Pharmaceuticals Reports 2023 Year-End Results
Contacts Betsy Brod Affinity Growth Advisors betsy.brod@affinitygrowth.com 212-661-2231 Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing...
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
NCE status provides a minimum of five years of regulatory exclusivityThe Company’s U.S. patents and pending patent applications related to...
SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Steering Committee Update on Phase 3 REGAL Study
- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled...
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
Philip Astley-Sparke to transition from current role of CEO to Executive ChairmanPlanned leadership changes position the Company for commercialization Read...
Northern California’s Venture Properties Joins Real
Brokerage with lifetime sales of nearly $2 billion expands Real’s growing presence in California Contacts Investor inquiries: Ravi Jani Vice...
Ocular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery)
BEDFORD, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to...
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Increases 2024 Treatment Site Activation Guidance to 20 Sites QUEENSBURY, N.Y., March 26, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq:...
FREEMAN COMMENCES PERMITTING INITIATIVES AT THE LEMHI GOLD DEPOSIT, IDAHO
Toronto Venture Stock Exchange: FMAN VANCOUVER, BC, March 26, 2024 /PRNewswire/ - Freeman Gold Corp. (TSXV: FMAN) (OTCQB: FMANF) (FSE:...
NEVADA KING REPORTS POSITIVE METALLURGICAL TEST RESULTS, CONFIRMS SUITABILITY OF CONVENTIONAL OXIDE PROCESSING METHODS AT ATLANTA
VANCOUVER, BC, March 26, 2024 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) ("Nevada King" or the "Company") is pleased...
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading...
Gilat Satellite Networks to Present at the 2024 LD Micro Invitational Conference
PETAH TIKVA, Israel, March 26, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in...
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
- Topline Results from SHINE Study in Mild-to-Moderate Alzheimer’s Expected mid-2024 -- On Track to Report Topline Results from SHIMMER...
Cardlytics Announces Proposed Convertible Senior Notes Offering
ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks’ digital channels, today...
Bragg Gaming Reports Fourth Quarter and Full Year 2023 Financial Results, Confirms Formation of Special Committee
Full Year 2023 Revenue Rises 10.4% to EUR 93.5 Million (USD 100.5 Million) and Adjusted EBITDA Grows 26.3% to EUR...
BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates
- Reported significant commercial progress for APHEXDA® -- secured payer coverage representing ~95% of covered lives in the U.S.; continued...
AvidXchange Announces Board Additions and Transitions
--Pre-IPO investors and current Board members Matthew Harris and Wendy Murdock to transition out--Tech and software business scaling executives Arthur...
American Lithium Strengthens Team and Launches Major ESG Initiative in Peru
VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | Nasdaq:AMLI...
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights
CHARLOTTESVILLE, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical...
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
Up to 3.3% Placebo-Adjusted Mean Weight Loss (5.3% from Baseline) Observed After 28 Days VK2735 Shown to be Safe and...
Virtu Financial Announces Fourth Annual Women in Data Science Conference
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq: VIRT), a global leader in financial technology, today...
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
– Reported positive interim data from Phase 2 IGNITE proof-of-concept clinical trial evaluating iluzanebart (VGL101) for treatment of ALSP ––...
Veritone Launches Ask Veri to Empower Customers to Talk to Their Data for Actionable Insights and Workflow Activation
New Generative AI media intelligence and natural language tool enables democratization of data exploration and activation to provide value from...
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
Review manuscript available in the journal Physiological Reviews Contacts Dewey Steadman at (202) 919-4097 https://ir.unither.com/contact-ir/ United Therapeutics Corporation (Nasdaq: UTHR),...
10 Barrel Brewing Unveils Newest Ready-to-Drink Canned Cocktails
BEND, Ore., March 26, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. (“10 Barrel”), an award-winning pioneer in the craft...
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
On track to achieve 250 patient enrollment target in March 2024 Top-line data for 32-week primary endpoint expected in the...
POET Enters Optical Module Market with 800G Transceiver for Artificial Intelligence Networks
TORONTO and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK;...
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic...
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Lead product candidate, nemvaleukin, is being developed to treat a wide range of solid tumors and is currently in two...
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222 Next-generation mRNA vaccine design offers the potential...
Laser Photonics To Attend NCMS Industry Day at Army Materiel Command Modernization Symposium With Its Selection of Laser Solutions
Contacts Investor Relations Contact: laser@haydenir.com Media Contact: Karla Kizzort Marketing Specialist Laser Photonics Corporation kkizzort@laserphotonics.com Laser Photonics Corporation (LPC) (NASDAQ:...